In that case, a high number of single nucleotide polymorphisms were found to be directly associated to cN-II expression and ara-C cytotoxicity or sensitivity in AML patients receiving the related chemotherapy [16]. This evidence concerns the gene NT5C2 and acute myeloid leukemia.